Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
29 1월 2025 - 10:07AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Amendment No. 28 to Schedule 13D, dated January 28, 2025, relating to the Common Shares, no par value, of Lineage Cell Therapeutics,
Inc. shall be filed on behalf of the undersigned.
Dated: January 28, 2025 |
Broadwood Partners, L.P.
|
|
By: |
Broadwood Capital, Inc. |
|
|
|
By: |
/s/ Neal C. Bradsher |
|
Name: |
Neal C. Bradsher |
|
Title: |
President |
|
|
|
|
|
|
|
Broadwood Capital, Inc. |
|
|
|
By: |
/s/ Neal C. Bradsher |
|
Name: |
Neal C. Bradsher |
|
Title: |
President |
|
|
|
|
|
|
|
/s/ Neal C. Bradsher |
|
Neal C. Bradsher |
Lineage Cell Therapeutics (AMEX:LCTX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Lineage Cell Therapeutics (AMEX:LCTX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025